136 related articles for article (PubMed ID: 11737735)
1. Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state.
Bayazit AK; Kilinç Y
Pediatr Int; 2001 Dec; 43(6):592-6. PubMed ID: 11737735
[TBL] [Abstract][Full Text] [Related]
2. Assessment of biochemical liver function tests in relation to age among steady state sickle cell anemia patients.
Akuyam SA; Abubakar A; Lawal N; Yusuf R; Aminu SM; Hassan A; Musa A; Bello AK; Yahaya IA; Okafor PA
Niger J Clin Pract; 2017 Nov; 20(11):1428-1433. PubMed ID: 29303127
[TBL] [Abstract][Full Text] [Related]
3. Coagulation profile of children with sickle cell anemia in steady state and crisis attending the university of Nigeria teaching hospital, Ituku-Ozalla, Enugu.
Chinawa JM; Emodi IJ; Ikefuna AN; Ocheni S
Niger J Clin Pract; 2013; 16(2):159-63. PubMed ID: 23563454
[TBL] [Abstract][Full Text] [Related]
4. Protein C and antithrombin levels in patients with sickle cell anemia in Ahmadu Bello University Teaching Hospital Zaria, Nigeria.
Kusfa IU; Mamman AI; Aminu SM; Hassan A; Muktar HM
Niger J Clin Pract; 2017 Aug; 20(8):998-1001. PubMed ID: 28891545
[TBL] [Abstract][Full Text] [Related]
5. Protein C and protein S in homozygous sickle cell disease: does hepatic dysfunction contribute to low levels?
Wright JG; Malia R; Cooper P; Thomas P; Preston FE; Serjeant GR
Br J Haematol; 1997 Sep; 98(3):627-31. PubMed ID: 9332318
[TBL] [Abstract][Full Text] [Related]
6. Hypercoagulability and hypofibrinolysis in sickle-cell disease.
Stathakis NE; Papayannis AG; Papayatos H; Scliros P; Gardikas C
Blut; 1975 Dec; 31(6):355-60. PubMed ID: 1203541
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease.
Nsiri B; Gritli N; Bayoudh F; Messaoud T; Fattoum S; Machghoul S
Hematol Cell Ther; 1996 Jul; 38(3):279-84. PubMed ID: 8974793
[TBL] [Abstract][Full Text] [Related]
8. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonographic spleen size and haematological parameters in children with sickle cell anaemia in Kano, Nigeria.
Abdullahi SU; Hassan-Hanga F; Ibrahim M
Niger Postgrad Med J; 2014 Jun; 21(2):165-70. PubMed ID: 25126872
[TBL] [Abstract][Full Text] [Related]
10. Role of hepatic enzymes in the biochemical assessment of the severity of sickle cell anemia.
Oparinde DP; Oghagbon EK; Okesina AB; Olatunji PO; Ojuawo AO
Trop Gastroenterol; 2006; 27(3):118-21. PubMed ID: 17310554
[TBL] [Abstract][Full Text] [Related]
11. The use of coagulation activation markers (soluble fibrin polymer, TpP, prothrombin fragment 1.2, thrombin-antithrombin, and D-dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders.
Arkel YS; Paidas MJ; Ku DH
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):199-205. PubMed ID: 11943933
[TBL] [Abstract][Full Text] [Related]
12. Laboratory investigation of hypercoagulability.
Francis JL
Semin Thromb Hemost; 1998; 24(2):111-26. PubMed ID: 9579632
[TBL] [Abstract][Full Text] [Related]
13. Heamostatic and genetic predisposing factors for stroke in children with sickle cell anemia.
Mourad H; Fadel W; El Batch M; Rowisha M
Egypt J Immunol; 2008; 15(1):25-37. PubMed ID: 20306667
[TBL] [Abstract][Full Text] [Related]
14. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
Koc A; Gumruk F; Gurgey A
Pediatr Hematol Oncol; 2003 Sep; 20(6):429-34. PubMed ID: 14631615
[TBL] [Abstract][Full Text] [Related]
15. Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion.
Liesner R; Mackie I; Cookson J; McDonald S; Chitolie A; Donohoe S; Evans J; Hann I; Machin S
Br J Haematol; 1998 Dec; 103(4):1037-44. PubMed ID: 9886316
[TBL] [Abstract][Full Text] [Related]
16. Thromboelastographic characterization of the activated clotting system in children with sickle cell trait or sickle cell disease.
Gupta S; Carmona R; Malvar J; Young G
Thromb Res; 2017 Mar; 151():44-50. PubMed ID: 28110132
[TBL] [Abstract][Full Text] [Related]
17. Changes in the blood coagulation, fibrinolysis, and cytokine profile during laparoscopic and open cholecystectomy.
Schietroma M; Carlei F; Mownah A; Franchi L; Mazzotta C; Sozio A; Amicucci G
Surg Endosc; 2004 Jul; 18(7):1090-6. PubMed ID: 15136925
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia.
Shome D; Al-Jamea L; Woodman A; Salem AH; Bakhiet M; Taha S; Sandhu AK; Al-Yami FS; Waheed KB; Elnagi EA; Almish M; Quiambao JV
Arch Gynecol Obstet; 2024 Jun; 309(6):2447-2458. PubMed ID: 37401942
[TBL] [Abstract][Full Text] [Related]
19. Serum zinc level during and after acute painful episodes in children with sickle cell anemia at the aminu kano teaching hospital, Kano, Northern Nigeria.
Kudirat AA; Shehu UA; Kolade E; Ibrahim M
Niger J Clin Pract; 2019 Jan; 22(1):16-23. PubMed ID: 30666015
[TBL] [Abstract][Full Text] [Related]
20. Reduced protein C levels--a contributory factor for stroke in sickle cell disease.
Khanduri U; Gravell D; Christie BS; Al Lamki Z; Zachariah M; Cherian E
Thromb Haemost; 1998 Apr; 79(4):879-80. PubMed ID: 9569210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
